Can Amino Acid Supplementation Augment the Anabolic Response in Tendon After Exercise
1 other identifier
interventional
7
1 country
1
Brief Summary
The goal of this study is to determine if an oral provision of amino acids will enhance exercise-induced increases in markers of Achilles tendon collagen production.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2017
CompletedFirst Submitted
Initial submission to the registry
August 20, 2019
CompletedFirst Posted
Study publicly available on registry
August 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2022
CompletedApril 11, 2023
April 1, 2023
5.6 years
August 20, 2019
April 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Achilles peritendinous concentrations of pro-collagen
Peritendinous samples will be collected using microdialysis. Pro-collagen will be assessed using enzyme immunoassay kits
0-6 hours post consumption
Amino Acid Levels
Achilles peritendinous amino acid concentrations will be assess using high performance liquid chromatography.
0-6 hours post consumption
Study Arms (2)
Young
EXPERIMENTAL21-30 year old men and women Inclusion/Exclusion Criteria 1. All subjects will be sedentary or recreationally active (sedentary: one day or less per week of aerobic or resistance exercise for at least a year or recreationally active: not training for competitive events). 2. Age: 21-30 years 3. Body mass index \<35 kg•m-2, 4. Chronic users of medications such as acetaminophen, ibuprofen, or prescription cyclooxygenase inhibitors will be excluded as these medications have been shown to alter tendon physiology. 5. Individuals with diabetes will be excluded. Diabetes is thought to change the structure of tendon. 6. Individuals with a history of tendon pain will be excluded, as chronic tendon pain is associated with changes in the structure of tendon. 7. Persons with allergies/sentivitiy to amino acids or ingedianet of Cystal Light will be excluded.
Older Adults
EXPERIMENTALInclusion/Exclusion Criteria 1. All subjects will be sedentary or recreationally active (sedentary: one day or less per week of aerobic or resistance exercise for at least a year or recreationally active: not training for competitive events). 2. Age: 60-75 years 3. Body mass index \<35 kg•m-2 4. Chronic users of medications such as acetaminophen, ibuprofen, or prescription cyclooxygenase inhibitors will be excluded as these medications have been shown to alter tendon physiology. 5. Individuals with diabetes will be excluded. Diabetes is thought to change the structure of tendon. 6. Individuals with a history of tendon pain will be excluded, as chronic tendon pain is associated with changes in the structure of tendon. 7. Persons with allergies/sentivitiy to amino acids or ingedianet of Cystal Light will be excluded.
Interventions
Eligibility Criteria
You may qualify if:
- years or 60-80 years old
You may not qualify if:
- diabetes
- BMI\>35
- acute illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, metabolic disorders, arthritis, or a history of neuromuscular problems.
- chronic pain medication users
- alcoholism
- competitive athletes
- pregnant women will be excluded
- Individuals with specific allergies to amino acids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Purdue University
West Lafayette, Indiana, 47907, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chad C Carroll, PhD
Purdue University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 20, 2019
First Posted
August 26, 2019
Study Start
May 9, 2017
Primary Completion
December 13, 2022
Study Completion
December 20, 2022
Last Updated
April 11, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share